Anabolic Anti Estrogen Steroids / Fulvestrant Faslodex For Female Breast Cancer Treatment
1 . Product Description
Alias: Faslodex
CAS: 129453-61-8
MF: C32H47F5O3S
MW: 606.77
Assay: 99% min.
Packing: 10 grams/foil bag
Delivery: Courier.
Grade : Pharmaceutical Grade
Storage: Shading, confined preservation
Manufacturer:Kafen
2 . COA
Test Item |
Specification |
Results |
Appearance |
A white to off-white crystalline powder |
White crystalline powder |
Identification |
The retention time of the major peak in the chromatogram of the assay preparation is same as that of the standard preparation obtained in the assay |
Conform |
Any Individual impurity |
Not more than 0.10% |
0.18% |
Total impurities |
Not more than 1.0% |
0.44% |
Ratio of isomers |
Fulvestran A |
50.0%-60.0% |
51.70% |
Fulvestran B |
40.0%-50.0% |
47.86% |
Purity |
>99.0% |
99.56% |
3 . Applications
Many breast cancers are stimulated to grow by the female sex hormones oestrogen and progesterone. These breast cancers are called hormone sensitive or hormone receptor positive. Drugs that block the effects of these hormones can slow or stop the growth of the breast cancer cells. Fulvestrant stops oestrogen getting to the cancer cells by blocking oestrogen receptors and reducing the number of receptors the cancer cell has.
Fulvestrant Acetate (Faslodex, AstraZeneca) is a drug treatment of hormone receptor-positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. It is an estrogen receptor antagonist with no agonist effects, which works by down-regulating the estrogen receptor.
Fulvestrant Acetate is a selective estrogen receptor down-regulator (SERD). Fulvestrant is indicated for the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following anti-estrogen therapy. The dosing schedule for fulvestrant remains under investigation in an attempt to optimize its effectiveness.
4 . Related product Anti Estrogen Steroids
Anastrozole |
Anti the side effects of steroids |
Tamoxifen citrate |
Estrogen antagonist,antineoplastic |
Exemestane |
Help fight breast cancer |
Letrozole |
The treatment of advanced breast cancer in women |
Clomiphine Citrate |
A drug treatment that stimulates your ovaries to release eggs |
Toremifene Citrate |
Originally developed to fight breast cancer, bodybuilders |
5 . You may need
Product name |
CAS NO. |
Product name |
CAS NO. |
Benzocaine |
94-09-7 |
Procaine |
59-46-1 |
Dapoxetine Hydrochloride |
129938-20-1 |
Tetracaine HCl |
136-47-0 |
Clobetasol Propionate |
25122-46-7 |
L-Thyroxine |
51-48-9 |
Finasteride |
98319-26-7 |
Dydrogesterone |
152-62-5 |
Theophylline |
58-55-9/ 5967-84-0 |
Valdecoxib |
181695-72-7 |
Procaine HCl |
51-05-8 |
Lidocaine HCl |
73-78-9 |
Lidocaine |
137-58-6 |
Benzocaine HCl |
23239-88-5 |
Dapoxetine |
119356-77-3 |
L-Epinephrine hydrochloride |
55-31-2/ 329-63-5 |
Chloramphenicol |
56-75-7/ 2787-09-9 |
Doxorubicin hydrochloride |
25316-40-9 |
Omeprazole |
73590-58-6/ 119141-89-8 |
Benzyl benzoate |
120-51-4 |
Dutasteride |
164656-23-9 |
Cyanocobalamin |
68-19-9/18195-32-9/ 13408-78-1 |
Acetaminophen |
103-90-2 |
Paromomycin |
7542-37-2 |
Amikacin disulfate salt |
39831-55-5/ 149022-22-0 |
Nitazoxanide |
55981-09-4 |
Dexamethasone sodium phosphate |
55203-24-2/ 312-93-6 |
Secnidazole |
3366-95-8 |
Trestolone acetate |
6157-87-5 |
Tinidazole |
19387-91-8 |
Lincomycin hydrochloride |
7179-49-9 |
Chlorhexidine Gluconate |
18472-51-0 |
Clotrimazole |
23593-75-1 |
1,3-dimethyl-pentylamine
hydrochloride |
105-41-9 |
1,3-Dimethylbutylamine hydrochloride |
71776-70-7 |
4 amino-2-Methylpentane citrate(AMP Citrate) |
71776-70-0 |
|
Anabolic Anti Estrogen Steroids / Fulvestrant Faslodex For Female Breast Cancer Images
|